Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.36 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7438325 | 0.85 | ATM (0.41) | ATML3MBTL1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL12344306 | 0.83 | ATM (0.40) | ATML3MBTL1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL11911981 | 0.83 | ATM (0.40) | ATML3MBTL1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL14663964 | 0.83 | ATM (0.40) | ATML3MBTL1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL7701248 | 0.81 | ATM (0.39) | ATML3MBTL1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL11786688 | 0.81 | ATM (0.43) | ATML3MBTL1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL705886 | 0.81 | ATM (0.39) | ATML3MBTL1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL129959 | 0.79 | ATM (0.38) | ATML3MBTL1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL21725633 | 0.79 | RIPK1 (0.39) | ATML3MBTL1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL1826870 | 0.78 | ALDH1A1 (0.37) | ATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8207273-B2 | Block copolymers useful as tensioning agents | RHODIA CHIMIE (FR) | 2012-06-26 | — | — | US | disclosed |
| EP-1858940-B1 | NON COSMETIC COMPOSITION COMPRISING A BLOCK COPOLYMER USEFUL AS TENSIONER | RHODIA CHIMIE SA (FR) | 2012-04-25 | — | — | EP | disclosed |
| EP-2113003-B1 | DIBLOCK COPOPLYMER INCLUDING UNITS DERIVED FROM STYRENE AND UNITS DERIVED FROM ACRYLIC ACID | RHODIA OPERATIONS (FR) | 2011-12-21 | — | — | EP | disclosed |
| US-20100113666-A1 | DIBLOCK COPOLYMER INCLUDING UNITS DERIVED FROM STYRENE AND UNITS DERIVED FROM ACRYLIC ACID | RHODIA SERVICES (FR) | 2010-05-06 | — | — | US | disclosed |
| EP-2113003-A1 | DIBLOCK COPOPLYMER INCLUDING UNITS DERIVED FROM STYRENE AND UNITS DERIVED FROM ACRYLIC ACID | Rhodia Opérations (FR) | 2009-11-04 | — | — | EP | disclosed |
| US-20090269299-A1 | Cosmetic Method for use in Smoothing the Skin | L'OREAL (FR) | 2009-10-29 | — | — | US | disclosed |
| US-20090221756-A1 | Block Copolymers Useful as Tensioning Agents | RHODIA CHIMIE (FR) | 2009-09-03 | — | — | US | disclosed |
| EP-1951377-B1 | COSMETIC METHOD FOR USE IN SMOOTHING THE SKIN | OREAL (FR) | 2009-06-03 | — | — | EP | disclosed |
| EP-1865918-B1 | COSMETIC USE OF A PARTICULAR COPOLYMER AS SKIN TENSOR IN A COSMETIC COMPOSITION | OREAL (FR) | 2009-05-06 | — | — | EP | disclosed |
| US-20080233077-A1 | Cosmetic Use of a Particular Copolymer as Skin Tensor in a Cosmetic Composition | L'OREAL (FR) | 2008-09-25 | — | — | US | disclosed |
| WO-2008090063-A1 | DIBLOCK COPOPLYMER INCLUDING UNITS DERIVED FROM STYRENE AND UNITS DERIVED FROM ACRYLIC ACID | RHODIA OPERATIONS (FR) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008087211-A1 | O/W EMULSION WITH BLOCK POLYMERS | L'OREAL (FR) | 2008-07-24 | — | — | WO | disclosed |
| WO-2008086928-A1 | O/W COSMETIC EMULSION COMPRISING A LIPOPHILIC UV SCREENING AGENT, A POLAR OIL AND A POLYSTYRENE-BLOCK-POLY(ACRYLIC ACID-STAT-C1-C4 ALKYL ACRYLATE) DIBLOCK COPOLYMER | L'OREAL (FR) | 2008-07-24 | — | — | WO | disclosed |
| WO-2008087212-A1 | EMULSION STABILIZED WITH BLOCK POLYMERS | L'OREAL (FR) | 2008-07-24 | — | — | WO | disclosed |
| WO-2008087119-A1 | COSMETIC COMPOSITION COMPRISING A DIBLOCK COPOLYMER | L'OREAL (FR) | 2008-07-24 | — | — | WO | disclosed |
| EP-1865918-A1 | COSMETIC USE OF A PARTICULAR COPOLYMER AS SKIN TENSOR IN A COSMETIC COMPOSITION | L'Oréal (FR) | 2007-12-19 | — | — | EP | disclosed |
| EP-1858940-A1 | BLOCK COPOLYMER USEFUL AS TENSOR | RHODIA CHIMIE (FR) | 2007-11-28 | — | — | EP | disclosed |
| WO-2006097641-A1 | BLOCK COPOLYMER USEFUL AS TENSOR | RHODIA CHIMIE (FR) | 2006-09-21 | — | — | WO | disclosed |
| WO-2006097529-A1 | COSMETIC USE OF A PARTICULAR COPOLYMER AS SKIN TENSOR IN A COSMETIC COMPOSITION | L'OREAL (FR) | 2006-09-21 | — | — | WO | disclosed |
| US-4006194-A | Production of phenols | THE LUMMUS COMPANY (US) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090269299-A1 | Cosmetic Method for use in Smoothing the Skin | CUTA, GLA, DSG1 | ATM 1870/4885L3MBTL1 4067/4885RIPK1 3845/4885 |
| US-20080233077-A1 | Cosmetic Use of a Particular Copolymer as Skin Tensor in a Cosmetic Composition | CUTA, MATR3, MSH6 | ATM 167/4885L3MBTL1 2803/4885RIPK1 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.